Cargando…

Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course vs Prolonged-Course Antibiotic Therapy

BACKGROUND: The recommended duration of antibiotic treatment for Enterobacteriaceae bacteremia is between 7 and 14 days. We compared the clinical outcomes of patients receiving short-course (6–10 days) vs prolonged-course (11–15 days) antibiotic therapy for Enterobacteriaceae bacteremia. METHODS: A ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chotiprasitsakul, Darunee, Han, Jennifer H, Conley, Anna T, Cosgrove, Sara E, Harris, Anthony D, Lautenbach, Ebbing, Tamma, Pranita D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631848/ http://dx.doi.org/10.1093/ofid/ofx162.075

Ejemplares similares

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

1588. Clinical Prediction Tool for Extended-Spectrum Β Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
por: Wang, Rebecca, et al.
Publicado: (2018)

212. Outcomes of Adults with Uncomplicated Staphylococcus aureus Bacteremia Receiving Short-Course Vs. Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2019)

52. Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia
por: Bae, Esther Y, et al.
Publicado: (2020)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019)

Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?
por: Tamma, Pranita D, et al.
Publicado: (2018)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

1174. Epidemiology of Carbapenem-Resistant Enterobacteriaceae, a 5-Year Experience at a Tertiary Care Hospital
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2018)

Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2019)

1071. Impact of Standard vs. Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients With Hematologic Malignancies
por: Cheung, Edna, et al.
Publicado: (2018)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

713 Short vs Long Courses of Antibiotic Treatment in Adults with Uncomplicated Gram-negative Bacteremia in a Tertiary Inistituition
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

1511. Effect of Discharge Antibiotic Route on Clinical Outcomes in Children with Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis with Bacteremia
por: Olson, Jared, et al.
Publicado: (2019)

1800. Clinical Impact of Real-Time Predictive Model to Facilitate Antibiotic Prescribing in Gram-Negative Bacteremia
por: Hamilton, Keith W, et al.
Publicado: (2018)

1116. Comparison of Short-Course vs. Prolonged-Course Antimicrobial Therapy in the Management of Intra-Abdominal Infections
por: Phlamon, Mina, et al.
Publicado: (2018)

Use of a Precision Antibiotic Therapy (PAT) Prediction Model to Identify Multidrug-Resistant (MDR) Enterobacteriaceae
por: Varga, Alexandra, et al.
Publicado: (2017)

1881. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Results From a National Antibiotic Stewardship Intervention of 402 United States (US) Hospitals
por: Tamma, Pranita, et al.
Publicado: (2019)

Predictive Value of Urinalysis and Recent Antibiotic Exposure to Distinguish Between Bacteriuria, Candiduria, and No-Growth Urine
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2021)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

Short‐course versus long‐course antibiotic treatment in patients with uncomplicated gram‐negative bacteremia: A systematic review and meta‐analysis
por: Li, Xiaoming, et al.
Publicado: (2020)

A framework for implementing antibiotic stewardship in ambulatory care: Lessons learned from the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use
por: Keller, Sara C., et al.
Publicado: (2022)

Prevent Antibiotic overUSE (PAUSE): Impact of a Provider Driven Antibiotic-Time out on Antibiotic Use and Prescribing
por: Thom, Kerri, et al.
Publicado: (2017)

2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses
por: Marini, Rachel V, et al.
Publicado: (2018)

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms
por: Simner, Patricia J, et al.
Publicado: (2018)

The Impact of Mental Health on Antibiotic Prescribing
por: Keller, Sara C., et al.
Publicado: (2022)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?
por: Alhashem, Fatema, et al.
Publicado: (2017)

848. Low-Bioavailability vs. High-Bioavailability Oral Antibiotics for the Definitive Treatment of Enterobacteriaceae Bacteremia from Suspected Urine Source in Hospitalized Veterans
por: Sutton, Jesse D, et al.
Publicado: (2019)

Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
por: Hsu, Alice J, et al.
Publicado: (2023)

161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic
por: Keller, Sara C, et al.
Publicado: (2021)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

639. Short Course Therapy for Urinary Tract Infections (SCOUT) in Children
por: Zaoutis, Theoklis, et al.
Publicado: (2020)

Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals
por: Tamma, Pranita D., et al.
Publicado: (2021)

Short Course of Antibiotic Therapy for Gram-Negative Bacilli Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation: Less Is Possible
por: Herrera, Fabián, et al.
Publicado: (2023)

Impact of PBP2a Assay on Antibiotic Therapy of Patients with Non-Blood, Non-Urine Staphylococcus aureus Infections
por: Shulder, Stephanie, et al.
Publicado: (2017)

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
por: Chiotos, Kathleen, et al.
Publicado: (2018)

Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
por: Cherian, Jerald, et al.
Publicado: (2023)

Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses
por: Appaneal, Haley J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hm30b5dsanlecoqm6g0648s786